Skip to main content

Featured

Market Cools as Nvidia’s Blowout Earnings Fail to Ignite Futures

  U.S. stock futures were mixed Thursday morning as investors digested Nvidia’s latest blockbuster earnings—results that impressed on paper but didn’t translate into broad market enthusiasm. Dow futures edged slightly higher, while S&P 500 and Nasdaq futures hovered near the flatline, reflecting a cautious mood across Wall Street. Nvidia delivered strong beats on quarterly revenue and profit, along with guidance that topped expectations. Despite the stellar numbers, the stock’s initial surge faded as traders questioned whether the AI boom can continue delivering outsized returns. Shares ultimately pared gains to under 1% in early trading. The broader market’s hesitation stems from growing concerns about the sustainability of heavy AI investment. Salesforce’s weaker outlook added to the uncertainty, dragging software shares and reinforcing fears that not all tech giants will benefit equally from the AI wave. Meanwhile, geopolitical tensions—including renewed U.S.–Iran nuclea...

article

Mpox Emerges as Global Health Crisis: Africa Declares Emergency

 

In a concerning development, the World Health Organization (WHO) has declared mpox a public health emergency of international concern for the second time. This decision comes on the heels of a similar continental emergency declaration by African health officials. The virus, known for causing painful, pus-filled lesions and severe illness, first gained global attention in 2022. Although case counts cooled down after widespread vaccination efforts, this year presents a more grim situation.

Across 18 African nations, thousands of infections have been reported, with a highly-transmissible variant spreading beyond the borders of the Democratic Republic of Congo (DRC). Even vulnerable newborns are falling ill in overcrowded hospitals. The lack of necessary vaccines and therapeutics in hotspots exacerbates the crisis. Year-to-date, Africa has seen over 15,000 mpox cases and nearly 500 deaths, representing a 160% increase compared to 2023.

Toronto, too, faces a resurgence of mpox cases. Officials urgently advise at-risk residents to get vaccinated. Africa’s Centers for Disease Control and Prevention (Africa CDC) estimates a need for 10 million mpox vaccine doses, but the continent has procured only 200,000 doses so far. Coordinated international efforts are crucial to halt these outbreaks and save lives.

Stay informed, stay vigilant, and prioritize vaccination to combat this global health crisis.


Comments